Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - November 2019

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Imiquimod (Zyclara®) has been accepted for restricted use in the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic, visible or palpable actinic keratosis of the full face or balding scalp in immunocompetent adults when other topical treatment options are contraindicated or less appropriate. The restriction limits use to the treatment of large field actinic keratosis (>25cm2).

Pentosan polysulfate sodium (Elmiron®) has been accepted for the treatment of bladder pain syndrome characterised by either glomerulations or Hunner’s lesions in adults with moderate to severe pain, urgency and frequency of micturition. It is noted that this decision takes account of the benefits of a Patient Access Scheme (PAS) that improves the cost-effectiveness of pentosan polysulfate sodium. This advice is contingent upon the continuing availability of the PAS in NHSScotland or a list price that is equivalent or lower.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - November 2019' on Email Share 'SMC Update - November 2019' on Delicious Share 'SMC Update - November 2019' on Digg Share 'SMC Update - November 2019' on Facebook Share 'SMC Update - November 2019' on reddit Share 'SMC Update - November 2019' on Twitter

CKS Updates - October 2019

During October 2019 Clinical Knowledge Summaries were published or updated in the following areas.

The Hearing loss in adults topic is new. The Halitosis topic has been updated in line with current evidence. The Shingles topic contains updated recommendations on antiviral treatment. It is recommended that antiviral treatment should be considered for all people aged over 50 years because while it has a low risk of complications, it does not significantly reduce the incidence of post-herpetic neuralgia. The other topics have undergone reviews and minor restructures.

Action: Clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice.

Share 'CKS Updates - October 2019' on Email Share 'CKS Updates - October 2019' on Delicious Share 'CKS Updates - October 2019' on Digg Share 'CKS Updates - October 2019' on Facebook Share 'CKS Updates - October 2019' on reddit Share 'CKS Updates - October 2019' on Twitter

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer